Authored pieces
News
Fieldfisher advises on Roquefort Therapeutics £31.9m acquisition, equity raise and AIM admission
04.03.2026
European law firm, Fieldfisher, has advised SP Angel Corporate Finance LLP and Shard Capital Partners LLP, acting as Nomad and Joint Brokers, on Roquefort Therapeutics plc’s proposed acquisition of a novel oncology asset valued at £31.9 million, alongside an £8.5 million equity raise and the company’s transition from the Main Market to the AIM market of the London Stock Exchange.